Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...

Catalent provides contract manufacturing services and performs fill-finish work, which involves the sterile filling and ...

Oct 14 (Reuters) - Catalent (CTLT.N), opens new tab has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug ...

SOMERSET, N.J. - Catalent, Inc. (NYSE ... has reached a definitive agreement to divest its Somerset, New Jersey oral solids development and small-scale manufacturing facility.

SOMERSET, N.J. - Catalent, Inc. (NYSE: NYSE:CTLT), a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, has reached a ...

(Reuters) - Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on ...

Catalent (CTLT) sells Somerset, NJ facility to Ardena. Corporate headquarters to shift to new location post-transition.